ID   HOK-1
AC   CVCL_B403
SY   HOK-I
DR   Wikidata; Q54890130
RX   PubMed=1714884;
CC   Population: Caucasian.
CC   Doubling time: 29.6 hours (PubMed=1714884).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
RX   PubMed=1714884; DOI=10.1002/ijc.2910490123;
RA   Offner F.A., Ott G., Povey S., Knuechel R., Preisler V., Fuezesi L.,
RA   Klosterhalfen B., Ruebben H., Hofstadter F., Kirkpatrick C.J.;
RT   "Characterization of the new bladder cancer cell line HOK-1:
RT   expression of transitional, squamous and glandular differentiation
RT   patterns.";
RL   Int. J. Cancer 49:122-128(1991).
//